日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

3H-pyrazolo[4,3-f]quinoline hinge binder, a tunable scaffold for development of novel kinase inhibitors against FLT3-driven leukemia

3H-吡唑并[4,3-f]喹啉铰链结合剂,一种可用于开发新型抗FLT3驱动白血病激酶抑制剂的可调支架

Dayal, Neetu; Řezníčková, Eva; Hernandez, Delmis E; Peřina, Miroslav; Bělíček, Jakub; Vojáčková, Veronika; Krňávková, Petra; Bařina, Marek; Brauer, Nickolas R; Hunjan, Mandeep Kaur; Yadav, Pratik; Jorda, Radek; Sintim, Herman O

Isoxazole-Based Compounds Targeting the Taxane-Binding Site of Tubulin.

靶向微管蛋白紫杉烷结合位点的异噁唑类化合物

Peřina Miroslav, Kiss Márton A, Bělíček Jakub, Vojáčková Veronika, Veselá Denisa, Minorics Renáta, Zupko István, Frank Éva, Jorda Radek

Cyclin dependent kinase 4/6 inhibitor palbociclib synergizes with BCL2 inhibitor venetoclax in experimental models of mantle cell lymphoma without RB1 deletion

在不伴有RB1缺失的套细胞淋巴瘤实验模型中,细胞周期蛋白依赖性激酶4/6抑制剂帕博西尼与BCL2抑制剂维奈托克具有协同作用

Malarikova, Diana; Jorda, Radek; Kupcova, Kristyna; Senavova, Jana; Dolnikova, Alexandra; Pokorna, Eva; Kazantsev, Dmitry; Nozickova, Kristina; Sovilj, Dana; Bellanger, Celine; Chiron, David; Andera, Ladislav; Krystof, Vladimir; Strnad, Miroslav; Helman, Karel; Klanova, Magdalena; Trneny, Marek; Havranek, Ondrej; Klener, Pavel

Anticancer effect of zanubrutinib in HER2-positive breast cancer cell lines

zanubrutinib 对 HER2 阳性乳腺癌细胞系的抗癌作用

Dostálová, Hana; Jorda, Radek; Řezníčková, Eva; Kryštof, Vladimír

Synthesis and Structural Optimization of 2,7,9-Trisubstituted purin-8-ones as FLT3-ITD Inhibitors

2,7,9-三取代嘌呤-8-酮作为FLT3-ITD抑制剂的合成与结构优化

Tomanová, Monika; Kozlanská, Karolína; Jorda, Radek; Jedinák, Lukáš; Havlíková, Tereza; Řezníčková, Eva; Peřina, Miroslav; Klener, Pavel; Dolníková, Alexandra; Cankař, Petr; Kryštof, Vladimír